JNJ

225.05

-1.11%↓

ABT

92.61

+1.53%↑

MDT

83.08

-0.36%↓

115.32

-0.08%↓

VEEV

161.12

+0.17%↑

JNJ

225.05

-1.11%↓

ABT

92.61

+1.53%↑

MDT

83.08

-0.36%↓

115.32

-0.08%↓

VEEV

161.12

+0.17%↑

JNJ

225.05

-1.11%↓

ABT

92.61

+1.53%↑

MDT

83.08

-0.36%↓

115.32

-0.08%↓

VEEV

161.12

+0.17%↑

JNJ

225.05

-1.11%↓

ABT

92.61

+1.53%↑

MDT

83.08

-0.36%↓

115.32

-0.08%↓

VEEV

161.12

+0.17%↑

JNJ

225.05

-1.11%↓

ABT

92.61

+1.53%↑

MDT

83.08

-0.36%↓

115.32

-0.08%↓

VEEV

161.12

+0.17%↑

Home・Aandelen Lijst・Odonate Therapeutics Inc

O
Odonate Therapeutics Inc

Open

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Odonate Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 apr 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26 apr 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Major Central Bank -2-

24 apr 2026, 19:19 UTC

Acquisities, Fusies, Overnames

Intertek Group Rejects EQT's Revised Offer

26 apr 2026, 23:48 UTC

Marktinformatie

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26 apr 2026, 23:44 UTC

Winsten

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26 apr 2026, 23:44 UTC

Winsten

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26 apr 2026, 23:36 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Falls Amid Dollar's Strength -- Market Talk

26 apr 2026, 23:33 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26 apr 2026, 05:12 UTC

Winsten

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26 apr 2026, 05:12 UTC

Winsten

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26 apr 2026, 05:12 UTC

Winsten

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26 apr 2026, 05:12 UTC

Winsten

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24 apr 2026, 23:37 UTC

Acquisities, Fusies, Overnames

Scoring the Cook Era -- Barrons.com

24 apr 2026, 20:51 UTC

Acquisities, Fusies, Overnames

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Financial Services Roundup: Market Talk

24 apr 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

24 apr 2026, 20:39 UTC

Acquisities, Fusies, Overnames

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr 2026, 20:09 UTC

Winsten

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 apr 2026, 19:48 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 apr 2026, 19:25 UTC

Acquisities, Fusies, Overnames

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr 2026, 19:25 UTC

Acquisities, Fusies, Overnames

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 apr 2026, 19:22 UTC

Winsten

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 apr 2026, 19:06 UTC

Winsten

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 apr 2026, 19:05 UTC

Marktinformatie

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 apr 2026, 18:30 UTC

Acquisities, Fusies, Overnames

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 apr 2026, 18:28 UTC

Acquisities, Fusies, Overnames

Intertek Rejects Revised EQT Offer

24 apr 2026, 18:12 UTC

Marktinformatie

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 apr 2026, 18:06 UTC

Marktinformatie

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 apr 2026, 17:42 UTC

Winsten

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 apr 2026, 17:28 UTC

Winsten

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Peer Vergelijking

Prijswijziging

Odonate Therapeutics Inc Prognose

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

EBITDA

Operationele winst

Over Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.